Christopher Brooke
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher Brooke
Christopher Brooke is recorded as COO at Aytu Biopharma, Inc (AYTU). Aytu Biopharma, Inc reported in an 8-K filed October 6, 2023 that Christopher Brooke resigned as Chief Operating Officer, effective October 13, 2023. Aytu Biopharma, Inc reported in an 8-K filed November 15, 2022 that Christopher Brooke was appointed Chief Operating Officer, effective November 14, 2022.
“On October 3, 2023, Christopher Brooke resigned as Chief Operating Officer of Aytu BioPharma, Inc. (the "Company"), effective October 13, 2023, to pursue another opportunity at a development-stage biotechnology company.”
“Effective November 14, 2022, Aytu BioPharma, Inc. (the “Company”) appointed Christopher Brooke as Chief Operating Officer”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-11-14–present
-
2022-11-14–2023-10-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aytu Biopharma, Inc
Other people whose current roles at this company are on record from its filings.
- Joshua R. Disbrow CEO, Board Member
- John A. Donofrio, Jr. Chairman
- Gregory A. Gould CFO
- Ryan Selhorn CFO
- Abhinav Jain Board Member
- Beth Hecht Board Member
- Beth P. Hecht Board Member
- Carl C. Dockery Board Member
- Gerald McLaughlin Board Member
- John A. Donofrio Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.